Structural Formula (Ars05 0001 01)
Arsenic Trioxide Injection
Product Images NDC 25021-227
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Arsenic Trioxide (NDC 25021-227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label – Principal Display Panel – Vial Label (Ars05 0001 02)
This is a description of Trioxide, an injectable pharmaceutical product manufactured for SAGENT in India. It is a cytotoxic agent, supplied in a 10 mL single-dose vial, with a strength of 10 mg per 10 (18 (1 mg per mL). It is for intravenous use only and should be stored at room temperature with excursions permitted to 15° to 30°C. The container closure is not made with natural rubber latex. The package contains a caution for handling cytotoxic agents. The text also includes information about the sterilization process and storage of the product.*
Package Label – Principal Display Panel – Vial Label (Ars05 0001 03)
This is a drug with the NDC code 25021-227-06, which contains a concentration of 2mg per mL of an active ingredient capable of being toxic for cells. It was manufactured in India by an unknown company for Sagent, and the package contains a warning for the user advising careful handling of the drug.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
